113: After slow IPO, Gland Pharma finds more takers in secondary markets
Mark to Market
English - November 26, 2020 08:22 - 6 minutes - 5.77 MBBusiness News News market price finance podcast investing stock market entrepreneurship business business podcast money market share market entrepreneur Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 112: Unexciting privatisation news flow keeps a check on BPCL shares
Whoever stuck their neck out in the Gland Pharma IPO is already sitting on decent gains. For an issue that offered full allotment for every application in the non-institutional category, it’s been among the best-performing IPOs for investors. Tune in here for more details.